Seyma Basar Kılıc

Dr. Seyma Basar Kılıc

Aksaray University Training and Research Hospital
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 February 2022 in Biomolecules
Verified
Journal Article
Open access
PDF file
EDEcmel Mehmetbeyoglu Duman
Ecmel Mehmetbeyoglu Duman
LKLeila Kianmehr
Leila Kianmehr
MBmurat borlu
murat borlu
ZYZeynep Yılmaz
Zeynep Yılmaz
SKSeyma Basar Kılıc
Seyma Basar Kılıc
Minoo RassoulzadeganMinoo Rassoulzadegan
Minoo Rassoulzadegan
Functional long non-coding RNAs (lncRNAs) have been in the limelight in aging research because short telomeres are associated with higher levels of TERRA (Telomeric Repeat containing RNA). The genomic instability, which leads to short telomeres, is a mechanism observed in cell aging and in a class of cancer cells. Psoriasis, a skin disease, is a disorder of epidermal keratinocytes, with altered telomerase activity. Research on the fraction of nascent RNAs in hybrid with DNA offers avenues for new strategies. Skin and blood samples from patients were fractionated to obtain the RNA associated with DNA as a R-loop structure. The higher amount of TERRA levels attached with each chromosome end was found with psoriasis patients in blood and skin. In addition to telomeric TERRA, we evidenced accumulation of others non-coding RNA, such as non-telomeric TERRA and centromeric transcripts. Increased levels of non-coding RNAs attached to DNA correlates with a decreased in Ribonuclease HII (RNase-HII) transcript which means that overall unresolved DNA–RNA hybrids can ultimately weaken DNA and cause skin lesions. Since the genome is actively transcribed, cellular RNase-HII is essential for removing RNA from the DNA–RNA hybrid in controls of genome stability and epigenome shaping and can be used as a causal prognostic marker in patients with psoriasis.

7 March 2025 in Medicine
Verified
Journal Article
Open access
SKSeyma Basar Kılıc
Seyma Basar Kılıc
HEHuseyin Erdal
Huseyin Erdal
Psoriasis is a chronic immune-mediated disease characterized by systemic inflammation. In recent years, the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), systemic immune-inflammation index (SII), systemic inflammation response index (SIRI), and pan-immune-inflammation value (PIV) were shown to be important indicators of inflammation. The aim of the present study is to investigate NLR, PLR, SII, SIRI, PIV together in patients with psoriasis. This retrospective case-control study encompassed seventy-one individuals diagnosed with psoriasis and seventy healthy controls who underwent evaluation at the Dermatology clinics of Aksaray University Training and Research Hospital from January 2022 to January 2023. Inflammatory process indicators such as NLR, PLR, SII, SIRI, PIV were computed for analysis. A notable discovery from our research was the indication of a direct relationship between SII and Psoriasis Area Severity Index (PASI) scores. A statistically significant difference was found between the 2 groups in terms of neutrophils, lymphocytes, monocytes, and platelets (P < .05). The area under the curve of the SII score for psoriasis was 0.611. The optimal cutoff value of SII to predict psoriasis activation was 442.7, with 55.7% sensitivity and 45.7% specificity (95% confidence interval 0.518–0.704, P = .024). A positive correlation was observed between SII, PIV and PASI (P = .004, r = 0.34; P = .006, r = 0.32 respectively).There was no statistically significant distinction observed in the PLR indices between the groups (P > .05). The present study investigation demonstrates the potential utility of SII, SIRI, and PIV in assessing psoriasis patients. Moreover, the findings suggest that SII and PIV could function as an autonomous prognostic marker for individuals diagnosed with psoriasis.

24 August 2024 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
SKSeyma Basar Kılıc
Seyma Basar Kılıc
STserpil taheri
serpil taheri
EDEcmel Mehmetbeyoglu Duman
Ecmel Mehmetbeyoglu Duman
ESeda öksüm solak
eda öksüm solak
ZYZeynep Yılmaz
Zeynep Yılmaz
MBmurat borlu
murat borlu

31 October 2022 in medRxiv
Verified
Preprint
Open access
PDF file
SKSeyma Basar Kılıc
Seyma Basar Kılıc
STSerpil Taheri
Serpil Taheri
EDEcmel Mehmetbeyoglu Duman
Ecmel Mehmetbeyoglu Duman
ESEda Öksüm Solak
Eda Öksüm Solak
MRMinoo Rassoulzadegan
Minoo Rassoulzadegan
MBmurat borlu
murat borlu
Patients prone to psoriasis suffer after a breakdown of the epidermal barrier and develop poorly healing lesions with abnormal proliferation of keratinocytes. Strong inflammatory reactions with genotoxicity (short telomeres) suggest impaired immune defences with DNA damage repair response (DDR) in patients with psoriasis. Recent evidence indicates the existence of crosstalk mechanisms linking the DDR machinery and hormonal signalling pathways that cooperate to influence both progressions of many diseases and responses to treatment. The aim of this study was to clarify whether steroid biosynthesis and genomic stability markers are altered in parallel during the formation of psoriatic skin. Understanding between the interaction of the steroid pathway and DNA damage response is crucial to addressing underlying fundamental issues and managing resulting epidermal barrier disruption in psoriasis. Twenty patients with psoriasis and fifteen healthy volunteers were included in this study. Transcription levels of estrogen ( ESR1, ESR2 ), androgen ( AR ), glucocorticoid/mineralocorticoid receptors ( NR3C1, NR3C2 ), HSD11B1/HSD11B2 genes, and DNA damage sensors ( SMC1A, TREX1, TREX2, SSBP3, RAD1, RAD18, EXO1, POLH, HUS1 ) were determined by Real-Time-PCR in blood and skin samples (Lesional, non-lesional) from psoriasis and control groups. Results: We found that ESR1, ESR2, HSD11B1, NR3C1, NR3C2, POLH , and SMC1A transcripts were significantly decreased and AR, TREX1, RAD1 , and SSBP3 transcripts were increased dramatically in the lesional skin compared to skin samples of controls. As a result, we found that the regulation of the steroidogenic pathway was disrupted in the lesional tissue of psoriasis patients and that a sufficient glucocorticoid and mineralocorticoid response did not form and the estrogen/androgen balance was altered in favour of androgens. We suggest that an increased androgen response in the presence of DDR increases the risk of developing psoriasis. Although this situation may be the cause or the consequence of a disruption of the epidermal barrier, our data suggest developing new therapeutic strategies.

29 August 2025 in Medicine
Verified
Journal Article
Open access
SKSeyma Basar Kılıc
Seyma Basar Kılıc
HKHuzeyfe Kulu
Huzeyfe Kulu
HSHüseyin Salman
Hüseyin Salman
MBMurat Bektaş
Murat Bektaş
Psoriasis (PsO) is a chronic immune-mediated disease that affects the skin and nails. Several screening tools such as psoriasis epidemiology screening tool, psoriatic arthritis screening and evaluation, early arthritis for psoriatic patients (EARP), STRIPP, SIPAS, and TOPAS have been developed and validated for identifying patients with suspected psoriatic arthritis (PsA) in dermatology clinics. Herein, we aim to validate and evaluate the performance of TurPAS in patients with PsO compared to the EARP questionnaire. This cross-sectional study was carried out in collaboration between dermatology and rheumatology clinics at Aksaray University Hospital, a tertiary referral center. All patients were examined for dermatologic aspects in the dermatology outpatient clinic and TurPAS and EARP questionnaires were performed by the same dermatologist. The patients who met the CASPAR criteria were classified as PsA in addition to appropriate clinical findings. In our study, 119 patients (n = 72; 60.5% female) with PsO were included. Mean ± standard deviation age of the patients was 44.9 ± 14.3 (range; 18–83) years and the median (IQR) PsO duration was 10 (14) years. Median (IQR) TurPAS and EARP scores were 2 (3) and 3 (5), respectively. Overall, 39 patients (32.8%) met the CASPAR criteria and were classified as PsA. The best diagnostic accuracy was observed in ≥ 3 positive items with 82% and 70% sensitivity and specificity (positive predictive value: 57.1%, negative predictive value: 89%, likelihood ratio: 2.7, diagnostic accuracy: 74%) for TurPAS and ≥ 4 items with 74.4% and 86.3% (positive predictive value: 72.5%, negative predictive value: 87.3%, likelihood ratio: 5.4, diagnostic accuracy: 82.4%) for EARP. In our study, approximately one-third of patients with PsO were diagnosed as PsA. TurPAS had acceptable diagnostic performance compared to the EARP questionnaire.